Periodic Reporting for period 1 - SAL ETHVI (Innovative, easily applicable vaccine for poultry industry against five Salmonella serovars: Enteritidis, Typhimurium, Hadar, Virchow and Infantis – SAL ETHVI)

The main objective of the Phase 1 Feasibility Study was to validate technological and economic viability of our technology and product in view of its potential future commercialization. The feasibility of SAL ETHVI project was fully confirmed during 5 months of Phase 1...